STEM-PD

N/A

Report date: 2026/05/12 20:00:17

Base Information

Drug NameSTEM-PD
Drug Alias Namehuman embryonic stem cell derived dopaminergic cells (Skane University Hospital/University of Cambridge/University Hospitals NHS Foundation Trust/Imperial College London)STEM-PD
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Neurogenic potential stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSkane University Hospital
China Registration ClassN/A

Develop Information

Active CompaniesSomite Therapeutics IncSkane University HospitalUniversity Of Cambridge +[5] 
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A